Federal contract award
36C26123N0747
PLUVICTO PROSTATE CANCER THERAPY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 261-NETWORK CONTRACT OFFICE 21 (36C261) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79719D0169 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.1M |
| Current contract value | $2.1M |
| Potential contract value / ceiling | $2.1M |
| Start date | Jul 26, 2023 |
| Current end date | Sep 30, 2024 |
| Potential end date | Sep 30, 2024 |
| Latest award activity | Dec 5, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 5, 2024 | P00003 | $-227.2K | PLUVICTO PROSTATE CANCER THERAPY, INCREASE QTY |
| Dec 5, 2024 | P00004 | $-3.3M | PLUVICTO PROSTATE CANCER THERAPY, INCREASE QTY |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.